NIH-funded research NIH-funded research

Understanding how Chlamydia bacteria grow and divide without a key protein.

Official title: Investigating the function of bacterial cytoskeletal elements in the division and growth of the FtsZ-less Chlamydia

Funded at University of Nebraska Medical Center · NIH-10763761 · Data updated 2026-11-12

This study is looking at how Chlamydia bacteria grow and divide, especially the types that don't use a key protein usually needed for this process, to help us understand how these infections work and why they can be hard to detect, which could lead to better treatments for those affected.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$394,470
NIH project number1R35GM151971-01
Project IDNIH-10763761 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are at risk of Chlamydia infections, particularly those in developing countries where the disease burden is high.

Less likely to help

Patients who are not affected by Chlamydia or those who have already been effectively treated for the infection may not benefit from this research.

What this research studies

This research investigates the unique mechanisms that Chlamydia bacteria use to grow and divide, particularly focusing on those strains that lack the FtsZ protein, which is typically essential for bacterial division. By studying the bacterial cytoskeletal elements and their roles in the division process, the research aims to uncover new insights into how these pathogens operate within host cells. This could lead to a better understanding of Chlamydia infections, which often go undiagnosed and can result in serious health issues. The methodology includes advanced cellular and molecular techniques to analyze the growth patterns and division processes of Chlamydia.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies for Chlamydia infections, potentially reducing the incidence of related diseases such as infertility and blindness.

How similar studies have gone: Previous research has shown success in understanding bacterial division mechanisms, but this specific approach to studying FtsZ-less Chlamydia is relatively novel.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Ouellette, Scot P — University of Nebraska Medical Center
  • Study coordinator: Ouellette, Scot P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.